Document is current
Any future updates will be listed below
-
Authors
Feinkohl, Insa
Hadzidiakos, Daniel
Dschietzig, Thomas B.
Janke, Jürgen
Heinrich, Maria
Slooter, Arjen J.C.
Spies, Claudia
Winterer, Georg
Pischon, Tobias
-
Funding
Funding for this research was provided by:
Universität Potsdam
- License Information
-
More Information
Article History
Received: 27 January 2025
Accepted: 6 December 2025
First Online: 20 December 2025
Declarations
:
: GW is coordinator of the BioCog consortium and is chief executive of the company Pharmaimage Biomarker Solutions GmbH (http://www.pi-pharmaimage.com). Among other academic and private partners, the company is a partner of the BioCog study. CD and TP are project leaders in BioCog. TBD is an employee of Immundiagnostik, the manufacturer of the CRP and S100A12 kits. The other authors have no competing interests.
: The study was conducted in compliance with the Declaration of Helsinki. The study protocol was approved by the institutional ethics review boards in Berlin, Germany (EA2/092/14), and Utrecht, Netherlands (14–469).
: All participants gave written informed consent.
